| Literature DB >> 35892926 |
Eisuke Nakazawa1, Katsumi Mori1, Makoto Udagawa1, Akira Akabayashi1,2.
Abstract
Neuroenhancement is rapidly re-emerging as a research topic because of the development of minimally invasive brain intervention technologies, including neurofeedback. However, public attitude toward enhancement technologies remains relatively unexplored. To fill this gap in the literature, we conducted an online survey of 1258 people in Japan who were presented with four scenarios depicting minimally and highly invasive enhancement interventions. Approximately 20% of the respondents stated that they were willing to use enhancement technologies, whereas 80% were not. Most respondents were cautious about using enhancement technologies. We used a generalized linear mixed-effects model to study the association between the type of intervention and participants' willingness to use such technologies. Factors related to willingness to use these technologies included interventions' degree of invasiveness, as well as participants' gender, educational attainment, and limit or suppression experiences. We also examined the influence of others' choices and behaviors, and participants' tolerance toward others' use of enhancement technologies. We explored important aspects of policymaking vis à vis enhancement technologies. This study could provide valuable insights for a debate on the ethics and regulation of enhancement technologies.Entities:
Keywords: Japan; empirical study; enhancement; ethics; technology regulation; willingness
Year: 2022 PMID: 35892926 PMCID: PMC9326753 DOI: 10.3390/biotech11030021
Source DB: PubMed Journal: BioTech (Basel) ISSN: 2673-6284
Scenarios depicting the use of enhancement technologies.
| Scenario | Intervention Target | Intervention Means | Scenario Summary |
|---|---|---|---|
| A | Cognition (concentration) | Minimally invasive (MRI) | Improve concentration by conducting simple training under MRI before studying for an important qualification examination. Training for 2 h × 4 days necessary. Almost no side effects. Costs approximately JPY 40,000. |
| B | Cognition (concentration) | Highly invasive (drug) | Improve concentration by taking drugs typically used to treat a specific illness before studying for an important qualification examination. Taken daily until test. Possibility of mild side effects. Costs approximately JPY 10,000. |
| C | Emotion (personality) | Minimally invasive (MRI) | Improve positivity and cheerfulness to make a good impression at a job interview by conducting simple training under MRI. Training for 2 h × 4 days necessary. Few side effects. Costs approximately JPY 40,000. |
| D | Emotion (personality) | Highly invasive (drug) | Improve positivity and cheerfulness to make a good impression at a job interview by taking drugs typically used to treat specific illnesses. Take daily until the test. Possibility of mild side effects. Costs approximately JPY 10,000. |
Respondents’ attributes and limit/suppression experiences.
|
| (%) | ||
|---|---|---|---|
| Gender | Male | 618 | (49.1%) |
| Female | 640 | (50.9%) | |
| Age (years) | 20–39 | 403 | (32.0%) |
| 40–64 | 551 | (43.8%) | |
| >65 | 304 | (24.2%) | |
| Highest educational attainment | Junior high school/high school | 414 | (32.9%) |
| Vocational school, junior and technical college | 276 | (21.9%) | |
| University/graduate school | 556 | (44.2%) | |
| Do not wish to answer | 12 | (1.0%) | |
| Household income | <JPY 4 million | 432 | (34.3%) |
| JPY 4–8 million | 377 | (30.0%) | |
| >JPY 8 million | 187 | (14.9%) | |
| Do not know/do not wish to answer | 262 | (20.8%) | |
| Residence | Non-urban area | 802 | (63.8%) |
| Urban area | 456 | (36.2%) | |
| Limit/suppression experience | Limit experience present | 401 | (31.9%) |
| Limit experience absent but suppression experience present | 403 | (32.0%) | |
| Both absent | 454 | (36.1%) |
Attitude toward the use of enhancement technology.
| Scenario A | Scenario B | Scenario C | Scenario D | |||||
|---|---|---|---|---|---|---|---|---|
| Willingness to use enhancement technology | ||||||||
| Wish to use | 374 | (29.7%) | 293 | (23.3%) | 378 | (30.0%) | 297 | (23.6%) |
| Do not wish to use | 884 | (70.3%) | 965 | (76.7%) | 880 | (70.0%) | 961 | (76.4%) |
| Synchronization with other people’s usage behavior | ||||||||
| Synchronize | 268 | (21.3%) | 238 | (18.9%) | 267 | (21.2%) | 238 | (18.9%) |
| Do not synchronize | 990 | (78.7%) | 1020 | (81.1%) | 991 | (78.8%) | 1020 | (81.1%) |
| Intolerance toward use by others | ||||||||
| Cannot tolerate | 273 | (21.7%) | 273 | (21.7%) | 246 | (19.6%) | 269 | (21.4%) |
| Can tolerate | 985 | (78.3%) | 985 | (78.3%) | 1012 | (80.4%) | 989 | (78.6%) |
| Government regulation | ||||||||
| Should be fully banned | 238 | (18.9%) | 270 | (21.5%) | 225 | (17.9%) | 252 | (20.0%) |
| Does not need to be fully banned | 1020 | (81.1%) | 988 | (78.5%) | 1033 | (82.1%) | 1006 | (80.0%) |
Factors related to attitudes toward the use of enhancement technologies.
| a. Factors related to attitudes toward the use of enhancement technologies ( | |||||||
| Willingness to use enhancement technology | Synchronization with other people’s usage behavior | ||||||
| AOR (95% CI) | AOR (95% CI) | ||||||
| Intervention target | Cognitive (concentration) | - | - | ||||
| Emotional (personality) | 0.988 | (0.825, 1.182) | 0.891 | 0.902 | (0.741, 1.097) | 0.301 | |
| Intervention means | Minimally invasive (MRI) | - | - | ||||
| Highly invasive (drugs) | 0.612 | (0.511, 0.734) | <0.001 | 1.010 | (0.829, 1.231) | 0.922 | |
| Gender | Male | - | - | ||||
| Female | 0.573 | (0.410, 0.800) | 0.001 | 1.194 | (0.876, 1.628) | 0.262 | |
| Age (years) | 20–39 | - | - | ||||
| 40–64 | 0.762 | (0.525, 1.106) | 0.153 | 0.752 | (0.532, 1.062) | 0.105 | |
| >65 | 0.765 | (0.495, 1.181) | 0.226 | 0.862 | (0.578, 1.287) | 0.469 | |
| Highest educational attainment | Junior high/high and | - | - | ||||
| vocational school, junior and technical college | 1.524 | (0.962, 2.412) | 0.072 | 1.193 | (0.788, 1.807) | 0.404 | |
| University/graduate school | 1.938 | (1.323, 2.837) | 0.001 | 0.826 | (0.578, 1.179) | 0.291 | |
| Household income (JPY) | <4 million | - | - | ||||
| 4–8 million | 1.134 | (0.792, 1.623) | 0.492 | 1.368 | (0.981, 1.908) | 0.065 | |
| >8 million | 1.096 | (0.694, 1.729) | 0.695 | 1.482 | (0.970, 2.263) | 0.069 | |
| Residence | Non-urban | - | - | ||||
| Urban | 1.124 | (0.807, 1.566) | 0.489 | 1.056 | (0.777, 1.434) | 0.729 | |
| Limit/suppression experience | Limit experience present | - | - | ||||
| Suppression experience only | 0.718 | (0.487, 1.058) | 0.094 | 0.776 | (0.542, 1.110) | 0.165 | |
| Both absent | 0.611 | (0.412, 0.908) | 0.015 | 0.726 | (0.504, 1.046) | 0.086 | |
| Willingness to use | Want to use | - | |||||
| Do not want to use | 7.994 | (6.203, 10.302) | <0.001 | ||||
| b. Factors related to attitudes toward the use of enhancement technologies ( | |||||||
| Intolerance toward use by others | Government regulation | ||||||
| AOR (95% CI) | AOR (95% CI) | ||||||
| Intervention target | Cognitive (concentration) | - | - | ||||
| Emotional (personality) | 0.878 | (0.717, 1.077) | 0.212 | 0.866 | (0.701, 1.069) | 0.180 | |
| Intervention means | Minimally invasive (MRI) | - | - | ||||
| Highly invasive (drugs) | 1.206 | (0.983, 1.478) | 0.072 | 1.270 | (1.027, 1.570) | 0.027 | |
| Gender | Male | - | - | ||||
| Female | 0.510 | (0.356, 0.732) | 0.000 | 1.204 | (0.829, 1.749) | 0.329 | |
| Age (years) | 20–39 | - | - | ||||
| 40–64 | 0.667 | (0.450, 0.987) | 0.043 | 1.010 | (0.661, 1.545) | 0.962 | |
| >65 | 0.340 | (0.209, 0.551) | <0.001 | 1.426 | (0.877, 2.317) | 0.152 | |
| Final educational background | Junior high/high and | - | - | ||||
| vocational school, junior and technical college | 1.606 | (0.987, 2.614) | 0.057 | 1.748 | (1.065, 2.868) | 0.027 | |
| University/graduate school | 1.087 | (0.720, 1.640) | 0.693 | 1.214 | (0.791, 1.864) | 0.375 | |
| Household income (JPY) | <4 million | - | - | ||||
| 4–8 million | 1.114 | (0.758, 1.636) | 0.584 | 0.937 | (0.627, 1.400) | 0.751 | |
| >8 million | 1.176 | (0.720, 1.920) | 0.517 | 1.269 | (0.761, 2.117) | 0.361 | |
| Residence | Non-urban | - | - | ||||
| Urban | 0.853 | (0.595, 1.224) | 0.388 | 0.664 | (0.455, 0.969) | 0.034 | |
| Limit/suppression experience | Limit experience present | - | - | ||||
| Suppression experience only | 0.819 | (0.537, 1.249) | 0.354 | 0.892 | (0.573, 1.390) | 0.613 | |
| Both absent | 1.025 | (0.672, 1.562) | 0.910 | 0.982 | (0.632, 1.525) | 0.935 | |
| Willingness to use | Want to use | - | - | ||||
| Do not want to use | 0.819 | (0.604, 1.111) | 0.199 | 0.310 | (0.216, 0.446) | <0.001 | |
Note: AOR = adjusted odds ratio; CI = confidence interval.